18-59436151-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_133459.4(CCBE1):​c.988-10A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00409 in 1,613,006 control chromosomes in the GnomAD database, including 239 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.022 ( 135 hom., cov: 32)
Exomes 𝑓: 0.0022 ( 104 hom. )

Consequence

CCBE1
NM_133459.4 intron

Scores

2
Splicing: ADA: 0.00001345
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -2.63

Publications

0 publications found
Variant links:
Genes affected
CCBE1 (HGNC:29426): (collagen and calcium binding EGF domains 1) This gene is thought to function in extracellular matrix remodeling and migration. It is predominantly expressed in the ovary, but down regulated in ovarian cancer cell lines and primary carcinomas, suggesting its role as a tumour suppressor. Mutations in this gene have been associated with Hennekam lymphangiectasia-lymphedema syndrome, a generalized lymphatic dysplasia in humans. [provided by RefSeq, Mar 2010]
CCBE1 Gene-Disease associations (from GenCC):
  • Hennekam lymphangiectasia-lymphedema syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • Hennekam syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 18-59436151-T-C is Benign according to our data. Variant chr18-59436151-T-C is described in ClinVar as Benign. ClinVar VariationId is 262357.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0739 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CCBE1NM_133459.4 linkc.988-10A>G intron_variant Intron 10 of 10 ENST00000439986.9 NP_597716.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CCBE1ENST00000439986.9 linkc.988-10A>G intron_variant Intron 10 of 10 1 NM_133459.4 ENSP00000404464.2

Frequencies

GnomAD3 genomes
AF:
0.0219
AC:
3323
AN:
152076
Hom.:
135
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0759
Gnomad AMI
AF:
0.00548
Gnomad AMR
AF:
0.00812
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000221
Gnomad OTH
AF:
0.0129
GnomAD2 exomes
AF:
0.00579
AC:
1454
AN:
250958
AF XY:
0.00444
show subpopulations
Gnomad AFR exome
AF:
0.0755
Gnomad AMR exome
AF:
0.00448
Gnomad ASJ exome
AF:
0.000993
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000274
Gnomad OTH exome
AF:
0.00440
GnomAD4 exome
AF:
0.00224
AC:
3266
AN:
1460812
Hom.:
104
Cov.:
30
AF XY:
0.00190
AC XY:
1381
AN XY:
726778
show subpopulations
African (AFR)
AF:
0.0745
AC:
2493
AN:
33456
American (AMR)
AF:
0.00478
AC:
214
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000957
AC:
25
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.000128
AC:
11
AN:
86222
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53414
Middle Eastern (MID)
AF:
0.00528
AC:
30
AN:
5682
European-Non Finnish (NFE)
AF:
0.000142
AC:
158
AN:
1111142
Other (OTH)
AF:
0.00555
AC:
335
AN:
60344
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
177
354
532
709
886
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
82
164
246
328
410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0219
AC:
3338
AN:
152194
Hom.:
135
Cov.:
32
AF XY:
0.0210
AC XY:
1561
AN XY:
74408
show subpopulations
African (AFR)
AF:
0.0761
AC:
3158
AN:
41508
American (AMR)
AF:
0.00811
AC:
124
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10596
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000221
AC:
15
AN:
68004
Other (OTH)
AF:
0.0128
AC:
27
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
148
297
445
594
742
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0147
Hom.:
27
Bravo
AF:
0.0250
Asia WGS
AF:
0.00606
AC:
21
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Hennekam lymphangiectasia-lymphedema syndrome 1 Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Nov 22, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.0040
DANN
Benign
0.47
PhyloP100
-2.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000013
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs115490148; hg19: chr18-57103383; API